핵심기술
특허 / 논문
| Influence of recombinant human interleukin (IL)-7 on disease progression in mice infected with friend virus complex. |
|---|
| 등록일 :2022-10-31 13:57 조회수 :196 |
|
Influence of recombinant human interleukin (IL)-7 on disease progression in mice infected with friend virus complex.
Lu L, Zhou Z, Wu B, Xiao M, Shen R-N, Williams DE, Kim Y-J, Kwon BS, Ruscetti S, Broxmeyer HE
Abstract Recombinant human (rhu) IL-7 was evaluated for its influence on disease progression in mice infected with the polycythemia-inducing strain of the Friend virus complex (FVC). DBA/2 mice were injected i.v. with FVC, and then treated s.c. with rhuIL-7. IL-7 significantly prolonged survival time and decreased spleen focus-forming virus (SFFV) levels, expression of SFFV mRNA and SFFV protein production in FVC-infected mice. IL-7 did not appear to directly inactivate SFFV. Although both splenic weight and cellularity in FVC-infected mice treated with IL-7 were higher than those of normal mice, they were respectively 58% and 66% lower than those of the untreated FVC-infected mice. NK-cell activity was substantially lower in FVC-infected mice than in normal mice, while IL-7 restored NK-cell activity to normal levels. IL-6 and IFN-gamma levels were markedly reduced in FVC-infected mice compared to normal mice, but treatment of FVC-infected mice with IL-7 restored these cytokine levels. While the actual mechanisms of these effects are not yet known, the results suggest the potential therapeutic efficacy of IL-7 for certain hematopoietic and viral disorders, possibly mediated through an action on accessory cells and cytokine production.
|